Vascular endothelial growth factor is increased by human pulmonary cells stimulated with Dermatophagoides sp. extract
Abstract:Airway remodeling may lead to increased secretion of TGF-. TGF- is known to activate fibroblasts and to stimulate the secretion of vascular endothelial growth factor (VEGF). Soluble and cell-associated VEGF have been identified in subjects with chronic severe asthma. Dermatophagoides sp. has been shown to contribute to the pathogenesis of asthma. The aim of this study was to determine if the Dermatophagoides sp. extract can stimulate confluent A549 (cA549) to express soluble or cell-associated VEGF and to secrete other factors that stimulate normal human lung fibroblasts (NHLFs) to secrete VEGF. Immunocytochemistry for cell-associated VEGF (pg/mL) was performed on cA549 stimulated with 300, 600, and 1000 AU/mL of dialyzed Dermatophagoides sp. extract for 24 hours with serum-free media (SFM). The subsequent conditioned media (CM) was transferred to NHLF for 24 hours (CM-NHLF). VEGF in CM, CM-NHLF, and control media (CTLM; extract without cA549) were measured by ELISA and normalized to cell density as measured by absorbance of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenol tetrazolium bromide at A550 nm (VEGF pg/mL:A550). Parametric data were analyzed by t-test or ANOVA at α = 0.05. Dermatophagoides sp. extract increased normalized VEGF secretion by cA549. Immunochemical VEGF expression by cA549 was increased qualitatively by Dermatophagoides sp. extract. The 1000 CM-NHLF showed increased normalized VEGF relative to CTLM. Dermatophagoides sp. stimulates cA549 to increase soluble and immunochemical VEGF and to secrete mediators that stimulate NHLF to increase secretion of VEGF. This suggests that inhalation of dust-mite allergen may stimulate airway cells to increase VEGF secretion, potentially contributing to edema in airway remodeling.
Document Type: Research Article
Affiliations: From the Nassau University Medical Center, East Meadow, New York, an affiliate of the State University of New York at Stony Brook, Department of Pathology, Divisions of Clinical Immunopathology and Allergy Immunology
Publication date: May 1, 2007
- Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.
Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
Articles marked "F" offer free full text for personal noncommercial use only.
The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
- Editorial Board
- Information for Authors
- Submit a Paper
- Information for Advertisers
- Reprint Requests
- ingentaconnect is not responsible for the content or availability of external websites